BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1853987)

  • 1. Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise.
    Keshavan MS; Kapur S; Pettegrew JW
    Am J Psychiatry; 1991 Aug; 148(8):976-85. PubMed ID: 1853987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear magnetic resonance spectroscopy: a review of neuropsychiatric applications.
    Passe TJ; Charles HC; Rajagopalan P; Krishnan KR
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):541-63. PubMed ID: 8588055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
    Soares JC; Krishnan KR; Keshavan MS
    Depression; 1996; 4(1):14-30. PubMed ID: 9160650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.
    Syrota A; Jehenson P
    Eur J Nucl Med; 1991; 18(11):897-923. PubMed ID: 1661237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy: current and future applications in psychiatric research.
    Lyoo IK; Renshaw PF
    Biol Psychiatry; 2002 Feb; 51(3):195-207. PubMed ID: 11839362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation of intramyocellular lipids by 1H-magnetic resonance spectroscopy.
    Boesch C; Kreis R
    Ann N Y Acad Sci; 2000 May; 904():25-31. PubMed ID: 10865706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and applications of in vivo clinical magnetic resonance spectroscopy.
    Cox IJ
    Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy in affective disorders.
    Kato T; Inubushi T; Kato N
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):133-47. PubMed ID: 9608402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance spectroscopy: a window for studying physiology.
    Horn M
    Methods Mol Med; 2006; 124():225-48. PubMed ID: 16506424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies.
    Negendank W; Li CW; Padavic-Shaller K; Murphy-Boesch J; Brown TR
    Anticancer Res; 1996; 16(3B):1539-44. PubMed ID: 8694523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy in myocardial disease.
    Beadle R; Frenneaux M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):269-77. PubMed ID: 20136613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9.
    Drost DJ; Riddle WR; Clarke GD;
    Med Phys; 2002 Sep; 29(9):2177-97. PubMed ID: 12349940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.
    Moore CM; Frederick BB; Renshaw PF
    J Geriatr Psychiatry Neurol; 1999; 12(3):107-17. PubMed ID: 10593699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance spectroscopy.
    Hope PL; Moorcraft J
    Clin Perinatol; 1991 Sep; 18(3):535-48. PubMed ID: 1934854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
    Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
    Port JD
    Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of human tumors by MRS: a review.
    Negendank W
    NMR Biomed; 1992; 5(5):303-24. PubMed ID: 1333263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography.
    Aboagye EO; Kelson AB; Tracy M; Workman P
    Anticancer Drug Des; 1998 Sep; 13(6):703-30. PubMed ID: 9755726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo NMR spectroscopy: investigation of brain metabolism in neonates and infants.
    Martin E; Grütter R; Boesch C
    Pediatrie; 1990; 45(10):677-82. PubMed ID: 2177545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and evaluation of CSI-localized J cross-polarization for detection of 31P magnetic resonance spectra in vivo.
    Mancini L; Payne GS; Leach MO
    Magn Reson Med; 2005 Nov; 54(5):1065-71. PubMed ID: 16200551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.